Claims for Patent: 9,556,445

Summary for Patent: 9,556,445

Title:	S-adenosylmethionine synthetase expression elements identified from Arabidopis thaliana
Abstract:	The present invention provides non-coding regulatory element polynucleotide molecules isolated from the S-adenosyl methionine synthetase (SAMS3) gene of Arabidopsis thaliana and useful for expressing transgenes in plants. The invention further discloses compositions, polynucleotide constructs, transformed host cells, transgenic plants and seeds containing the Arabidopsis thaliana regulatory polynucleotide sequences, and methods for preparing and using the same.
Inventor(s):	Wu; Wei (St. Louis, MO), Wang; Qi (St. Louis, MO), Edgerton; Michael (St. Louis, MO), Beazley; Kim (Kirkwood, MO), Deikman; Jill (Davis, CA), Petersen; Michael W. (Sauk City, WI), Zhang; Bei (Chesterfield, MO)
Assignee:	Monsanto Technology LLC (St. Louis, MO)
Application Number:	14/298,785
Patent Claims:	1. A regulatory polynucleotide molecule comprising the promoter sequence consisting of SEQ ID NO: 3 functional in a plant cell, wherein said promoter is operably linked to the intron sequence consisting of SEQ ID NO: 7; and wherein the regulatory polynucleotide molecule is operably linked to a heterologous transcribable polynucleotide molecule. 2. A polynucleotide construct comprising the regulatory polynucleotide molecule of claim 1. 3. The polynucleotide construct of claim 2, wherein said transcribable polynucleotide molecule is a gene of agronomic interest. 4. The polynucleotide construct of claim 2, wherein said transcribable polynucleotide molecule is a gene controlling the phenotype of a trait selected from the group consisting of: herbicide tolerance, insect control, modified yield, fungal disease resistance, virus resistance, nematode resistance, bacterial disease resistance, plant growth and development, starch production, modified oils production, high oil production, modified fatty acid content, high protein production, fruit ripening, enhanced animal and human nutrition, biopolymers, environmental stress resistance, pharmaceutical peptides and secretable peptides, improved processing traits, improved digestibility, enzyme production, flavor, nitrogen fixation, hybrid seed production, fiber production, and biofuel production. 5. The polynucleotide construct of claim 4, wherein said herbicide tolerance gene is selected from the group consisting of genes that encode for: phosphinothricin acetyltransferase, glyphosate resistant EPSPS, hydroxyphenyl pyruvate dehydrogenase, dalapon dehalogenase, bromoxynil resistant nitrilase, anthranilate synthase, glyphosate oxidoreductase and glyphosate-N-acetyl transferase. 6. A transgenic plant cell stably transformed with the polynucleotide construct of claim 2. 7. A transgenic plant stably transformed with the polynucleotide construct of claim 2. 8. A seed obtained from said transgenic plant of claim 7, wherein the seed comprises said polynucleotide construct. 9. A progeny plant grown from the seed of claim 8, wherein said progeny comprises said polynucleotide construct. 10. The transgenic plant cell of claim 6, wherein said plant cell is from a monocotyledonous plant selected from the group consisting of wheat, maize, rye, rice, corn, oat, barley, turfgrass, sorghum, millet and sugarcane. 11. The transgenic plant of claim 7, wherein said plant is a monocotyledonous plant selected from the group consisting of wheat, maize, rye, rice, corn, oat, barley, turfgrass, sorghum, millet and sugarcane. 12. A seed obtained from the transgenic plant of claim 11, wherein the seed comprises said polynucleotide construct. 13. The transgenic plant cell of claim 6, wherein said plant cell is from a dicotyledonous plant selected from the group consisting of tobacco, tomato, potato, soybean, cotton, canola, sunflower and alfalfa. 14. The transgenic plant of claim 7, wherein said plant is a dicotyledonous plant selected from the group consisting of tobacco, tomato, potato, soybean, cotton, canola, sunflower and alfalfa. 15. A seed obtained from the transgenic plant of claim 14, wherein the seed comprises said polynucleotide construct.

Details for Patent 9,556,445

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	For Injection	103132	06/04/1986		2018-11-16
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	For Injection	103132			2018-11-16
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	Injection	103132			2018-11-16